Page last updated: 2024-11-06

triethylenemelamine and Hemorrhage

triethylenemelamine has been researched along with Hemorrhage in 4 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Hemorrhage: Bleeding or escape of blood from a vessel.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
JUERGENS, P1
PLIESS, G1
ZEZZANETO, L1
SOERENSEN, B1
SALIBA, AM1
CORREA, HC1
MOLANDER, DW1
LADUE, JS1
Silver, RT1

Reviews

1 review available for triethylenemelamine and Hemorrhage

ArticleYear
The treatment of chronic lymphocytic leukemia.
    Seminars in hematology, 1969, Volume: 6, Issue:4

    Topics: Adrenal Cortex Hormones; Alkylating Agents; Anemia; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Ag

1969

Other Studies

3 other studies available for triethylenemelamine and Hemorrhage

ArticleYear
[The osmotic resistance of blood leukocytes in the rat after blood loss and triethylene melamine medication].
    Frankfurter Zeitschrift fur Pathologie, 1960, Volume: 70

    Topics: Animals; Biochemical Phenomena; Hemorrhage; Leukocytes; Osmosis; Rats; Triethylenemelamine

1960
[STUDY OF VARIOUS ORGANIC CHANGES PRODUCED BY ANTIBLASTIC CHEMOTHERAPY ADMINISTERED TO DOGS IN HIGH DOSES].
    Revista brasileira de cirurgia, 1963, Volume: 46

    Topics: Dogs; Gastrointestinal Hemorrhage; Hemorrhage; Pathology; Pharmacology; Research; Thiotepa; Toxicolo

1963
CHRONIC LEUKEMIA.
    Geriatrics, 1964, Volume: 19

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Alkylating Agents; Anemia; Anemia, Hemolytic,

1964